| |
| |
|
| Insider
Information: |
Yocca Frank |
| Relationship: |
Chief Scientific Officer |
| City: |
Branford |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
12,763 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$18,379 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
12,763 |
|
|
| Total
Value |
$18,379 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bioxcel Therapeutics Inc |
BTAI |
Chief Scientific Officer |
2024-04-04 |
12,763 |
2018-11-30 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
19 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-04-04 |
4 |
AS |
$2.64 |
$2,812 |
D/D |
(1,067) |
12,763 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-03-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,250 |
13,830 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2024-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
11,580 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-12-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
11,059 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-09-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
10,538 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
521 |
10,017 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-03-15 |
4 |
AS |
$19.69 |
$19,396 |
D/D |
(985) |
9,496 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-03-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,084 |
10,481 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2023-01-20 |
4 |
AS |
$30.00 |
$1,500,000 |
D/D |
(50,000) |
8,397 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-03-15 |
4 |
AS |
$48.47 |
$727,573 |
D/D |
(15,000) |
58,397 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-02-16 |
4 |
AS |
$55.88 |
$865,153 |
D/D |
(15,000) |
73,397 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-25 |
4 |
AS |
$46.94 |
$725,814 |
D/D |
(15,000) |
88,397 |
0 |
% |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2021-01-25 |
4 |
OE |
$0.41 |
$6,150 |
D/D |
15,000 |
103,397 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2020-02-14 |
4 |
OE |
$0.41 |
$32,800 |
D/D |
80,000 |
88,397 |
0 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2019-08-13 |
4 |
B |
$8.67 |
$56,762 |
D/D |
6,547 |
8,397 |
2.74 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-12-04 |
4 |
B |
$5.20 |
$2,339 |
D/D |
450 |
1,850 |
2.66 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-12-03 |
4 |
B |
$5.23 |
$2,353 |
D/D |
450 |
1,400 |
2.66 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-11-30 |
4 |
B |
$5.20 |
$2,340 |
D/D |
450 |
950 |
2.66 |
- |
|
| BTAI |
Bioxcel Therapeutics Inc |
Chief Scientific Officer |
• – – |
2018-11-29 |
4 |
B |
$5.02 |
$2,511 |
D/D |
500 |
500 |
2.66 |
- |
|
19 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
